Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Kisvarda

8 clinical trials in Kisvarda, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Kisvarda at a glance
8
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

8 trials in Kisvarda

Open in trial search
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Sponsor:Diamedica Therapeutics Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Human Plasma Gelsolin, Recombinant
  • Sponsor:Bioaegis Therapeutics Inc.

Ischaemic stroke

Not yet recruiting
Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Redasemtide
  • Sponsor:Shionogi B.V.

Muscle spasticity

Not recruiting
Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Botulinum Toxin Type A - Haemagglutinin Complex
  • Sponsor:Ipsen Innovation

Ischaemic stroke+2

Not recruiting
Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Asundexian
  • Sponsor:Bayer AG
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
  • Sponsor:Merz Pharmaceuticals GmbH
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Gadobutrol
  • Sponsor:Bayer AG
Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen - Cilag International

Other cities in Hungary

The busiest research cities in the country

All 70 cities in Hungary

Clinical research in Kisvarda

What the registry says about research in the country

01 Stroke Prevention & Treatment

Groundbreaking research focusing on ischemic stroke prevention and treatment, evaluating novel therapeutic approaches including oral inhibitors and specialized compounds.

  • Post-stroke Prevention
  • Transient Ischemic Attack Management
  • Blood Clot Prevention

Multiple studies are exploring innovative medications to reduce stroke recurrence risk in high-risk patients.

02 Neurological Imaging

Advanced research in contrast enhancement agents for magnetic resonance imaging, specifically targeting central nervous system pathology assessment.

  • Brain Imaging Advancement
  • Spinal Cord Diagnostics
  • MRI Enhancement Technology

Studies focus on developing safer and more effective contrast agents for neurological diagnosis.

03 Respiratory Medicine

Critical research into treatment options for Acute Respiratory Distress Syndrome, particularly cases resulting from pneumonia and other infections.

  • ARDS Treatment
  • Pneumonia Complications
  • Respiratory Care Innovation

Investigating novel protein-based therapies to improve patient outcomes in severe respiratory conditions.

04 Neuromuscular Disorders

Innovative treatments for lower limb spasticity, particularly focusing on post-stroke and traumatic brain injury complications.

  • Spasticity Management
  • Mobility Enhancement
  • Therapeutic Interventions

Clinical evaluation of specialized toxin treatments for improved muscle control and functionality.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.